14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today FULC ranks #15060 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Fulcrum Therapeutics, Inc. Stock Forecast NASDAQ:FULC

$15.73 (2.48%)

Volume: 221k

Closed: Dec 08, 2021

Hollow Logo Score: -2.423

Fulcrum Therapeutics, Inc. Stock Forecast

$15.73 (2.48%)

Volume: 221k

Closed: Dec 08, 2021

Score Hollow Logo -2.423
Which way will FULC go? Request
Key Stats
Beta 0.65
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 75 ] RSI14 is 38 and the stock is currently not being overbought or oversold

Green day on Wednesday for Fulcrum Therapeutics, Inc.
(Updated on Dec 08, 2021)

Sell candidate since 2021-10-18 Loss -31.73%

The Fulcrum Therapeutics, Inc. stock price gained 2.48% on the last trading day (Wednesday, 8th Dec 2021), rising from $15.35 to $15.73. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 9.08% from a day low at $14.76 to a day high of $16.10. The price has risen in 6 of the last 10 days and is up by 4.8% over the past 2 weeks. Volume fell on the last day by -214 thousand shares and in total, 221 thousand shares were bought and sold for approximately $3.48 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -47.79% during the next 3 months and, with a 90% probability hold a price between $6.63 and $9.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, December 01, 2021, and so far it has risen 12.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fulcrum Therapeutics, Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $18.70. On a fall, the stock will find some support from the short-term average at $14.68. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss

Fulcrum Therapeutics, Inc. finds support from accumulated volume at $15.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.34 between high and low, or 9.08%. For the last week, the stock has had a daily average volatility of 11.51%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Fulcrum Therapeutics, Inc. stock A Buy?

Fulcrum Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.423

Predicted Opening Price for Fulcrum Therapeutics, Inc. of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$15.53 $15.73 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 17, 2021 "HC Wainwright" gave "$20.00 - $40.00" rating for FULC. The price target was changed from $21.74 to 5.2%.

Volatility and Risk
Daily Average Volatility: 11.51 %
Overall Risk: Very High High Medium Low Very Low
11.51 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $17.14
Price: $15.73
Support: $15.20

FULC Insider Trading Show all Trades



Last 100 transactions
Buy: 1 724 318 | Sell: 4 284 138 (Shares)
Date Action Amount Person Type
Nov 10, 2021 Sell 1 000 000 Levin Mark J Common Stock
Nov 10, 2021 Sell 1 000 000 Third Rock Ventures Iii, L.p. Common Stock
Sep 22, 2021 Sell 1 000 000 Levin Mark J Common Stock
Sep 22, 2021 Sell 1 000 000 Third Rock Ventures Iii, L.p. Common Stock
Aug 11, 2021 Buy 28 000 Stuart Bryan Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 1 724 318 | Sell: 4 284 138 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 16.87 7.23 %
16.35 3.97 %
16.04 1.96 %
Current price: 15.73
Support 15.01 -4.55 %
14.70 -6.56 %
14.19 -9.81 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 19.47 23.78 %
19.03 20.98 %
17.14 8.96 %
Current price 15.73
Support 15.20 -3.37%
14.74 -6.29%
14.03 -10.81%

Click to get the best stock tips daily for free!

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE